PASADENA, Calif.--(BUSINESS WIRE)--Osmetech plc (‘Osmetech’) (LSE: OMH), the international molecular diagnostics business, announces that it has signed a five-year distribution agreement with Fisher HealthCare, a part of Thermo Fisher Scientific, whereby Fisher HealthCare will distribute Osmetech’s eSensor XT-8 instrument platform and molecular diagnostic tests and consumables in the U.S.
